Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
A method is described to amplify the delivery of 111In to human breast cancer cells utilizing a novel human serum albumin-human EGF (HSA-hEGF) bioconjugate substituted preferentially in the HSA domain with multiple DTPA metal chelators for 111In. 111In-DTPA-HSA-hEGF exhibited a lower receptor-bindin...
Үндсэн зохиолчид: | Wang, J, Chen, P, Su, Z, Vallis, K, Sandhu, J, Cameron, R, Hendler, A, Reilly, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2001
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
-н: Chen, P, зэрэг
Хэвлэсэн: (2002) -
111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
-н: Reilly, R, зэрэг
Хэвлэсэн: (2000) -
In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR
-н: Reilly, R, зэрэг
Хэвлэсэн: (2000) -
A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
-н: Reilly, R, зэрэг
Хэвлэсэн: (2000) -
The anti-tumor effect of the auger electron-emitting radiopharmaceutical, In-111-hEGF against MDA-MB-468 human breast cancer xenografts is tumor-size dependent.
-н: Chen, P, зэрэг
Хэвлэсэн: (2001)